Novelty in Biomedicine

Khosravi MH, Sharafi H, Alavian SM. HBV Infection Trend in Iranian Disabled Children; Is It really Worrying? Novel Biomed. 2017;5(1):48.

Davoodbeglou F, Mesdaghi M, Goudarzi H, Shojaei F, Aram H, Vaezjalali M. Evaluation of Hepatitis B Infection Prevalence in Institutionalized Intellectually Disabled Children. Novel Biomed. 2016;4(2):61-6.

Nespoli L1, Burgio GR, Ugazio AG, Maccario R.Immunological features of Down's syndrome: a review. J Intellect Disabil Res. 1993;37(6):543-51.

Nisihara R1, De Bem RS, Negreiros PH, Utiyama SR, Oliveira NP, Amarante H. Low hepatitis B vaccine response in children with Down syndrome from Brazil. Child Care Health Dev. 2014;40(4):607-9.

Coleman P. Detecting hepatitis B surface antigen mutants. Emerging Infectious Diseases. 2006;12(2):198-203.

Oon CJ, Chen WN. Current aspects of hepatitis B surface antigen mutants in Singapore. J Viral Hepat. 1998;5:17–23.

Lada O, Benhamou Y, Poynard T, Thibault V. Coexistence of Hepatitis B Surface Antigen (HBs Ag) and Anti-HBs Antibodies in Chronic Hepatitis B Virus Carriers: Influence of “a” Determinant Variants. J Virol. 2006;80(6):2968–75.

Colsona P, Borentainc P, Mottea A, Henrya M, Moald V, Botta-Fridlund D, Tamaleta C, Gérolamic R. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers. Virology. 2007;367(1):30–40